Home > Insider Trading > Filing (0001209191-14-075389)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1513818	Versartis Inc.	VSAR	Pharmaceutical Preparations (2834)	244106690

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1601949	Paul Westberg	C/O Versartis, Inc. 4200 Bohannon Drive, Suite 250 Menlo Park CA 94025	Sr. Vp, Business Development	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-12-11	6,946	$1.27	25,636	No	4	M	Direct
Common Stock	Disposition	2014-12-11	6,946	$18.51	18,690	No	4	S	Direct
Common Stock	Acquisiton	2014-12-12	3,054	$1.27	21,744	No	4	M	Direct
Common Stock	Disposition	2014-12-12	3,054	$18.65	18,690	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2014-12-11	6,946	$0.00	6,946	$1.27
Common Stock	Stock Option (Right to Buy)	Disposition	2014-12-12	3,054	$0.00	3,054	$1.27

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,271		2021-03-29	No	4	M	Direct
7,217		2021-03-29	No	4	M	Direct

Footnotes

Includes 1,190 shares purchased on 11/14/14 pursuant to the issuer's employee stock purchase plan.
Shares sold pursuant to a 10b5-1 trading plan.
The shares were sold at prices ranging from $18.12 to $19.01. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $18.20 to $18.97. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Twenty-five percent of the shares subject to the option vest on the first anniversary of the vesting commencement date and the remainder vest in equal monthly installments thereafter for 36 months.